Posts

Funding Opportunities for Journalists: 12th Heidelberg ...

This September, Heidelberg is poised to become a melting pot of vibrant intellec...

Discovery of DNA Alterations and Biological Pathways Li...

Researchers at Stanford University have made significant strides in understandin...

Devastating Wildfires in the Andes: Impacts on Soil Hea...

In September 2018, the Pichu Pichu volcano in Peru experienced a devastating wil...

One in Six Parents Endorse Non-Surgical Cosmetic Treatm...

For an increasing number of teenagers grappling with self-esteem issues related ...

Novel Lipid Nanoparticle Technology Enables mRNA Delive...

Scientists at the Icahn School of Medicine at Mount Sinai have recently develope...

Breakthrough in Catalyst Design Paves the Way for Eco-F...

In the quest for sustainable chemical processes, the production of ammonia—a cri...

Addressing Hidden Concerns: Psychology Professor Explor...

The conversation surrounding masculinity and the unique set of challenges faced ...

Revolutionary Insights: Cone Snail Venom Fuels Innovati...

In a groundbreaking study, scientists from the Weizmann Institute of Science hav...

Bristol Myers Cuts Off Allergy Asset In Spite of Phase ...

Bristol Myers Squibb has persisted with its aggressive cost-reduction strategy, ...

Biogen secures $250 million to finance phase 3 study

To forward a significant pipeline opportunity, Biogen has secured $250 million. ...

SpringWorks Gains FDA Green Light For Genetic Disorder ...

Following the recent statement by Merck KGaA that it is in advanced talks about ...

Abcuro Secures $200 Million to Advance Ulviprubart for ...

Abcuro, a biotechnology company backed by Sanofi, has secured $200 million in Se...

Revolutionary approaches to drug design: how AI is tran...

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples ...

Aardvark prices $94.2m IPO to fund development of Prade...

Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for...

Trump presidency signals potential downturn in NIH SBIR...

US President Donald Trump kicked off his second term with a series of directives...

SmartCella gains rights to advance cell therapy researc...

SmartCella has secured exclusive rights to advance research around cell replacem...